Moberg Pharma AB (publ) (STO:MOB)
Sweden · Delayed Price · Currency is SEK 10.19
-0.16 (-1.55%)
Mar 2, 2026, 5:17 PM CET
Moberg Pharma AB Revenue
In the year 2025, Moberg Pharma AB had annual revenue of 13.54M SEK with 37.99% growth. Moberg Pharma AB had revenue of 2.07M in the quarter ending December 31, 2025, with 101.36% growth.
Revenue
13.54M
Revenue Growth
+37.99%
P/S Ratio
35.38
Revenue / Employee
2.71M
Employees
5
Market Cap
478.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.54M | 3.73M | 37.99% |
| Dec 31, 2024 | 9.81M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 207.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 425.75M |
| Cinclus Pharma Holding AB | 57.47M |
| Nanexa AB | 55.94M |
| Enzymatica AB | 53.90M |
| Cereno Scientific AB | 44.27M |
| Newbury Pharmaceuticals AB | 36.76M |
| Orexo AB | 26.00M |
| Klaria Pharma Holding AB (publ.) | 8.99M |